Key Finding
This is the first standardized randomized controlled trial protocol designed to evaluate electroacupuncture for treating insomnia in patients with end-stage renal disease undergoing maintenance hemodialysis, using a 7-point improvement on the Insomnia Severity Index as the primary outcome measure.
Patients undergoing dialysis for end-stage kidney disease often struggle with severe insomnia, which significantly impacts their health and quality of life. Current treatment options are limited and not always effective. Researchers in China are testing whether electroacupuncture—a technique that combines traditional acupuncture with mild electrical stimulation—might help these patients sleep better.
This study is a pilot trial designed to establish whether a full-scale research project is worthwhile. Sixty dialysis patients with insomnia will be randomly divided into two groups. One group will receive real electroacupuncture three times weekly for four weeks, while the other receives sham (fake) acupuncture that looks similar but doesn't provide actual treatment. Neither patients nor researchers will know who receives which treatment until the study ends. Participants will be followed for eight weeks total, with the main assessment happening at week four.
The researchers will measure success by counting how many patients experience meaningful improvement in their insomnia symptoms, defined as at least a 7-point improvement on a standardized insomnia scale. They'll also track sleep quality through sleep diaries, quality of life surveys, fatigue levels, blood pressure, and blood markers of inflammation.
This is important because it's the first standardized study specifically examining electroacupuncture for insomnia in dialysis patients. While the results aren't available yet, if electroacupuncture proves effective, it could offer a safe alternative for patients who have few good options for treating their sleep problems. The study is registered in the Chinese Clinical Trial Registry, ensuring transparency and proper scientific oversight.
If considering acupuncture for any condition, seek a licensed acupuncturist with appropriate credentials and experience in your specific health concerns.
This pilot RCT (n=60) investigates electroacupuncture efficacy for insomnia in end-stage renal disease patients undergoing maintenance hemodialysis. Using a 1:1 randomization, participants receive either active EA or sham EA (3 sessions/week for 4 weeks) with follow-up at week 8. The primary outcome is response rate, defined as proportion achieving ≥7-point improvement on the Insomnia Severity Index at week 4—representing the minimal clinically important difference. Secondary measures include sleep diaries, PSQI, SF-12, FSS, 24-hour ambulatory blood pressure, and inflammatory biomarkers (CRP, D-Dimer). This represents the first standardized protocol specifically targeting this population, addressing a significant clinical gap given limited conventional treatment options for ESRD-related insomnia. The trial design includes appropriate blinding and sham control, strengthening validity. Results may inform future definitive trials and guide clinical application of EA in nephrology settings. Registered: ChiCTR2300071814.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Professor LU Jin's Tongfu Tiaoshen method treats insomnia caused by organ excess by combining abdominal acupuncture points to unblock organ qi with head points to calm the spirit and tongue pricking to drain turbidity.
📌 Digital CBT-I demonstrates optimal effectiveness at 250 minutes total treatment duration, achieving nearly 8-point improvement on the Insomnia Severity Index, with effects plateauing beyond 300 minutes.
📌 Dry eye disease patients with poor sleep quality showed significantly reduced corneal nerve fiber density and nearly double the inflammatory cell density compared to those with good sleep quality.